dnaS

DNA Selects VisualOn’s OnStream® Android TV to Deliver the Highest Quality of Service for Their Over the Top (OTT) Deployment on the Android TV Platform

Retrieved on: 
Monday, July 6, 2020

Launched in February this year, the new DNA TV has revamped DNAs TV offering for IP-based delivery, introducing multiple features including unlimited NPVR recordings, a new user interface and improved video stream quality.

Key Points: 
  • Launched in February this year, the new DNA TV has revamped DNAs TV offering for IP-based delivery, introducing multiple features including unlimited NPVR recordings, a new user interface and improved video stream quality.
  • Furthermore, the service delivers compelling content recommendations based on users individual viewing preferences.
  • VisualOn, powered by AWS, has closely supported DNA to build and deploy this platform.
  • Service reliability and a seamless user experience were at the top of our priority list when building the next-generation of DNA TV from the ground up, says Pekka Jskelinen, Head of Service Platforms, DNA Plc.

Applied DNA Enters Dietary Supplements Market with Multi-Year Nutrition21 Contract

Retrieved on: 
Wednesday, February 19, 2020

Applied DNA Sciences , Inc. (Applied DNA, the Company, NASDAQ: APDN), and Nutrition21, LLC (Nutrition21), announce the successful implementation of Applied DNAs CertainT authenticity and traceability solution for Nutrition21s leading sports supplement ingredient, Nitrosigine.

Key Points: 
  • Applied DNA Sciences , Inc. (Applied DNA, the Company, NASDAQ: APDN), and Nutrition21, LLC (Nutrition21), announce the successful implementation of Applied DNAs CertainT authenticity and traceability solution for Nutrition21s leading sports supplement ingredient, Nitrosigine.
  • Separately, a Broker Agreement was also signed between the parties to enable Nutrition21 to represent Applied DNAs CertainT platform throughout its extensive network in the dietary supplement market.
  • CertainT supports Nutrition21s investment in brand and intellectual property protection for its ingredients and its customers final products, said Dr. James Hayward, president and CEO, Applied DNA.
  • This tag can be blended into ingredients, packaging inks and varnishes in the pharmaceutical, functional food, and dietary supplements industries.

DNA Genetics Announces Sponsorship of WBO Boxing Champion, Patriot, and Olympian Jamel “Semper Fi” Herring

Retrieved on: 
Friday, December 13, 2019

LOS ANGELES, Dec. 13, 2019 (GLOBE NEWSWIRE) -- OG DNA Genetics (DNA or the Company), a globally recognized brand, today announced its partnership with Jamel Semper Fi Herring, the reigning WBO Junior Lightweight World Champion.

Key Points: 
  • LOS ANGELES, Dec. 13, 2019 (GLOBE NEWSWIRE) -- OG DNA Genetics (DNA or the Company), a globally recognized brand, today announced its partnership with Jamel Semper Fi Herring, the reigning WBO Junior Lightweight World Champion.
  • The teaming up with Herring comes on the heels of DNAs announcement of its sponsorship with WBC and WBA Boxing Champion, Seniesa Superbad Estrada.
  • The Herring deal is another step towards DNAs expansion into the CBD space and further bridges the gap between alternative wellness and the sporting community.
  • His dedication to boxing and his commitment to his country exhibit some of the same values DNA holds near and dear, said Charles Phillips, CEO of DNA Genetics.

Applied DNA Receives Extension from Nasdaq

Retrieved on: 
Thursday, October 3, 2019

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA) (we, us, our, the Company), a leader in large-scale PCR-based DNA manufacturing, today announced that the Nasdaq Hearings Panel (the Panel), has granted Applied DNAs request for an extension through December 31, 2019, to comply with all applicable criteria for continued listing of the Companys securities on The Nasdaq Capital Market (Nasdaq), including the minimum $1.00 bid price and $2.5 million stockholders equity requirements.

Key Points: 
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA) (we, us, our, the Company), a leader in large-scale PCR-based DNA manufacturing, today announced that the Nasdaq Hearings Panel (the Panel), has granted Applied DNAs request for an extension through December 31, 2019, to comply with all applicable criteria for continued listing of the Companys securities on The Nasdaq Capital Market (Nasdaq), including the minimum $1.00 bid price and $2.5 million stockholders equity requirements.
  • During the extension, Applied DNAs securities will remain listed on Nasdaq.
  • We are appreciative of the Nasdaq Hearings Panels decision to grant us our requested extension to evidence compliance with all applicable requirements for continued listing on Nasdaq.
  • Forward-looking statements describe Applied DNAs future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA.

DNA Genetics Moves To Consolidate Top California Cannabis Brands, Expanding Their Library of Best-In-Class Cultivars

Retrieved on: 
Tuesday, August 6, 2019

DNAs acquisition of Crockett Family Farms represents a joining of premier California cannabis genetics brands which will be integrated into a highly successful global licensing platform.

Key Points: 
  • DNAs acquisition of Crockett Family Farms represents a joining of premier California cannabis genetics brands which will be integrated into a highly successful global licensing platform.
  • As part of the agreement, DNA will bring on Dave Suderman (Crockett) as its Vice President of Cannabis Operations.
  • Crockett Family Farms has been a long-time partner of DNA Genetics working collaboratively to develop unique varieties renowned for their taste, smell, and popularity.
  • DNA is excited to formally welcome Crockett Family Farms into the DNA Army.

Applied DNA Signs MOU with Tex-Ray Industrial to Introduce CertainT® Authentication Platform to Global Textile Brands

Retrieved on: 
Monday, January 28, 2019

Applied DNAs CertainT molecular authentication platform for forensic authenticity and traceability delivers brand differentiation and protection of goods whose value chains span large commercial ecosystems and geographies.

Key Points: 
  • Applied DNAs CertainT molecular authentication platform for forensic authenticity and traceability delivers brand differentiation and protection of goods whose value chains span large commercial ecosystems and geographies.
  • Its global footprint offers the advantage of deep domain knowledge and staffing to implement CertainT from design through development to delivery across its customer base.
  • We believe Tex-Rays customers - manufacturers, retailers and brands - will benefit from our CertainT platform as a means of supporting claims in performance, sustainability and product origin.
  • Partnering with Applied DNA furthers our mission, enabling us to use the most reliable authentication solutions with the broadest applications.